Released on LinkedIn as well.
https://www.linkedin.com/pulse/polynovo-gains-singapore-regulatory-approval-paul-brennan/
PolyNovo is pleased to announce the successful registration of NovoSorb BTM with the Health Sciences Authority of Singapore. Sales of NovoSorb BTM in Singapore will occur only after the appointment of a distributor.
PolyNovo will be attending and displaying at the Asian Burns Conference in Singapore 14-16 August and this will be an excellent forum to meet with key surgeons and distributors across the region. PolyNovo is still awaiting CE certification.
CEO Paul Brennan said; “Singapore is a small but key strategic market for our SE Asian success. We are excited about the prospects ahead with this approval coming at a good time for our attendance and display at the Asia Burns conference in Singapore next week.”
Released on LinkedIn as...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
-0.050(1.95%) |
Mkt cap ! $1.739B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.60 | $2.51 | $2.348M | 921.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22274 | $2.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 10711 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |